Edited by Professor Anastasis Stephanou Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Contraindication Signals Standard conservative practice excludes anyone with active gastrointestinal disease, type 1 diabetes, prior pancreatitis, medullary thyroid carcinoma history, or active cancer from any retatrutide protocol
Tesamorelin Modified GHRH analog designed for enhanced stability. In research, reduces visceral adipose tissue while increasing GH and IGF-1
You can calculate your BMI using our BMI calculator
A lower-dose GLP-1/GIP protocol designed for women who want metabolic benefits energy, focus, sleep, lean body composition without aggressive weight loss
Science 368 , 8589 (2020)